NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. NVDA
3. SPCX
4. MU
5. LCO
6. KR
7. APGE
8. MSTR
9. ABBV
10. ICE

Go back to NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
NEOGENOMICS (NASDAQ: NEO) Delayed: 11.21 +0.08 (0.72%)
Previous Close $11.13    52 Week High $9.54 
Open $11.11    52 Week Low $5.49 
Day High $11.30    P/E 280.25 
Day Low $11.09    EPS $0.04 
Volume 236,166